If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Di Bartolomeo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 90 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y. J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., Sep 1 2019, In : Clinical Colorectal Cancer. 18, 3, p. 183-191.e3

Research output: Contribution to journalArticle

Open Access
  • Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

    Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y-J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., 2019, In : Clinical Colorectal Cancer. 18, 3, p. 183

    Research output: Contribution to journalArticle

    Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP): Clinical Colorectal Cancer

    Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y-J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., 2019, In : Clin Colorectal Cancer. 18, 3, p. 183

    Research output: Contribution to journalArticle

  • Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial

    Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, Tortora, G., Bonetti, A., Spallanzani, A., Frassineti, G. L., Tassinari, D., Giuliani, F., Cinieri, S., Maiello, E., Verusio, C., Bracarda, S., Catalano, V., Basso, M., Ciuffreda, L., De Vita, F., Parra, H. S., Fornaro, L., Caporale, M., De Braud, F. & Pietrantonio, F., Mar 29 2019, In : BMC Cancer. 19, 1, 283.

    Research output: Contribution to journalArticle

  • Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial

    Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, Tortora, G., Bonetti, A., Spallanzani, A., Frassineti, G. L., Tassinari, D., Giuliani, F., Cinieri, S., Maiello, E., Verusio, C., Bracarda, S., Catalano, V., Basso, M., Ciuffreda, L., De Vita, F., Parra, H. S., Fornaro, L., Caporale, M., De Braud, F. & Pietrantonio, F., Mar 29 2019, In : BMC Cancer. 19, 1, 283.

    Research output: Contribution to journalArticle